ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements
Consolidated Q2 FY27 revenue ₹884 Cr (+77%), EBITDA ₹128 Cr (14.4% margin), PAT ₹81 Cr. Price-led China-linked spike; receivables and working capital rising, debt flat.
H1FY27 consolidated revenue Rs15,991mn (+67% YoY), EBITDA Rs2,027mn (12.7% margin), PAT Rs1,118mn. Q2 posted record revenue and a 14.4% EBITDA margin.
Bodal Chemicals Ltd reported revenue from operations of ₹863.4 Cr (+79.7% YoY) and net profit of ₹81.4 Cr (+1256.7% YoY) for Q2 FY27.
Bodal Chemicals Limited has intimated a board meeting on 03 November 2026 to consider unaudited standalone and consolidated quarterly and half-year results, plus any other business. The trading window reopens 06 November 2026.
Bodal Chemicals Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Bodal Chemicals Limited conducted its 40th Annual General Meeting on September 25, 2026. The meeting successfully passed all proposed resolutions with the requisite majority.
Bodal Chemicals reported an inter-se promoter group transfer of 1,70,000 equity shares. Ramesh D Patel sold the stake to Ankit S. Patel for Rs. 3.39 Crore.
Ramesh D Patel, a member of the promoter group, sold 1,70,000 equity shares (0.13%) of Bodal Chemicals Ltd. The transaction occurred off-market on September 29, 2026.
Promoter Ankit S. Patel acquired 1,70,000 equity shares of Bodal Chemicals Ltd through an open market (inter-se) transaction. This increases his stake from 5.77% to 5.90%.
Promoter Ramesh D Patel sold 1,70,000 equity shares of Bodal Chemicals Ltd via open market. This transaction reduced the promoter's stake from 3.93% to 3.79%.
Bodal Chemicals Ltd conducted its 40th Annual General Meeting on September 25, 2026. Key business included adopting FY26 financial statements and ratifying auditor remuneration.
Bodal Chemicals Ltd. clarifies that news regarding a potential merger circulating on social media is false and baseless. The company confirms no such proposal exists.
Ashokkumar Giriraj Bansal acquired 1,75,000 shares of Bodal Chemicals Ltd via open market purchases. Post-acquisition, his total shareholding increased to 5.01%.
Bodal Chemicals Limited clarified that recent share price and volume fluctuations are purely market-driven. The company confirmed no undisclosed price-sensitive information exists that would impact trading behavior.
Bodal Chemicals Limited has filed its Annual Report for the financial year 2025-26. The 40th Annual General Meeting is scheduled for September 25, 2026.
Bodal Chemicals Limited has scheduled its 40th Annual General Meeting on September 25, 2026, through video conferencing to transact ordinary and special business.
Bodal Chemicals Limited will hold its 40th Annual General Meeting on September 25, 2026. The company set September 18, 2026, as the record date for e-voting.
Bodal Chemicals reported Q1FY27 consolidated revenue of Rs. 7,152 mn, up 56% YoY, and PAT of Rs. 304 mn, up 219% YoY. Strategy focuses on integrated production and downstream benzene derivative expansion.
Bodal Chemicals Ltd reported revenue from operations of ₹709 Cr (+56.1% YoY) and net profit of ₹30.4 Cr (+220.0% YoY) for Q1 FY27.
Bodal Chemicals will hold a board meeting on 05-Aug-2026 to approve standalone and consolidated financial results for the quarter ended June 2026.
Bodal Chemicals Ltd disclosed its shareholding pattern for the quarter ended 30 June 2026. Details of holdings by promoters, institutions and other categories are provided.
Bodal Chemicals submitted a Regulation 74(5) compliance certificate for the quarter ended 30 June 2026. The filing confirms dematerialisation of securities with MUFG Intime.
Bodal Chemicals submitted an unmodified audit opinion declaration for FY2026 results. The filing corrects a previous administrative oversight without changing financial outcomes.
Bodal Chemicals reported Q4FY26 revenue of ₹5,906mn (up 30% YoY) and PAT of ₹321mn. Full-year FY26 revenue reached ₹20,539mn with EBITDA margins improving to 9.9%.
Bodal Chemicals Ltd reported revenue from operations of ₹588 Cr (+30.4% YoY) and net profit of ₹32.1 Cr (+121.4% YoY) for Q4 FY26.
Bodal Chemicals reported a consolidated annual income of ₹2053.89 Crore for FY26. The Board also approved selling non-core Unit-I and Unit-II assets in Gujarat.
Bodal Chemicals scheduled a board meeting for May 21, 2026, to approve audited annual financial results. The trading window remains closed until May 24, 2026.
Bodal Chemicals Ltd submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. This routine filing confirms adherence to SEBI listing regulations.
Bodal Chemicals Ltd informed stock exchanges that it does not meet the criteria for a 'Large Corporate' for FY 2026-27 under SEBI norms. The company reported outstanding borrowings of ₹340.17 Crore as of March 31, 2026, and maintains an A-/Stable credit rating. This disclosure is for regulatory compliance regarding debt security issuance frameworks.
Bodal Chemicals Ltd reported net profit of ₹0.2 Cr (-96.3% YoY) for Q3 FY26.